Discussing Complementary Therapy Use With Early-Stage Breast Cancer Patients: Exploring the Communication Gap

Abstract

Objective. The current study aimed to (1) describe communication patterns between oncologists and breast cancer patients regarding the use of complementary and alternative medicine (CAM) and (2) assess the relationship between CAM discussions and anxiety levels. Methods. Interaction analysis of audiotaped initial consultations of 102 early-stage breast cancer patients with Australian and New Zealand oncologists was carried out. Preconsultation and postconsultation anxiety levels were assessed using the State-Trait Anxiety Inventory. Results. At least 1 instance of CAM discussion was found in 24 of the 102 consultations (24%). CAM discussions were mainly patient initiated (73%). The most common doctor’s response to a patient’s mention of CAM was encouragement (38%), although 23% of CAM references elicited a discouraging comment, and 20% were ignored. No patient demographics were significantly associated with CAM discussion. Patients who discussed CAM reported higher preconsultation and postconsultation anxiety levels than those who did not discuss CAM. Conclusions. CAM discussions during initial consultations between early-stage breast cancer patients and oncologists appear to be limited and linked with higher patient anxiety before and after the consultation. These findings indicate that doctors require further education about CAM therapies and supplements as well as guidance in how to raise and effectively discuss CAM issues with concern for their safety while balancing respect for the patients’ beliefs.

Keywords

breast cancer oncology doctor—patient communication complementary and alternative medicine (CAM)coding system anxiety

References

National Center for Complementary and Alternative Medicine (NCCAM). What is CAM? http://nccam.nih.gov/health/whatiscam/overview.htm. Accessed October 19, 2009.

Yates JS , Mustian KM , Morrow GR , et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806-811.

Rees RW , Feigel I. , Vickers A. , Zollman C. , McGurk R. , Smith C. Prevalence of complementary therapy use by women with breast cancer: a population-based survey. Eur J Cancer. 2000 ; 36:1359-1364.

Saxe GA , Madlensky L. , Kealey S. , Wu DPH , Freeman KL , Pierce JP Disclosure to physicians of CAM use by breast cancer patients: findings from the Women’s Healthy Eating and Living Study. Integr Cancer Ther. 2008;7:122-129.

Miller M. , Boyer MJ , Butow PN , Gattellari M. , Dunn SM , Childs A. The use of unproven methods of treatment by cancer patients: frequency, expectations and cost. Support Care Cancer. 1998;6:337-347.

Richardson MA , Sanders T. , Palmer JL , Greisiger A. , Singletary SE Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology . J Clin Oncol. 2000;18:2505-2514.

Moschen R. , Kemmler G. , Schweigkofler H. , et al. Use of alternative/complementary therapy in breast cancer patients: a psychological perspective. Support Care Cancer. 2001;9: 267-274.

Verhoef MJ , Hilsden RJ , O’Berine M. Complementary therapies and cancer care: an overview. Patient Educ Couns. 1999; 38:93-100.

Weiger WA , Smith M. , Boon H. , Richardson MA , Kaptchuk TJ , Eisenberg DM Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137:889-913.

10.

MacLennan AH , Wilson DH , Taylor AW Prevalence and cost of alternative medicine in Australia. Lancet. 1996;347: 569-573.

11.

Cohen L. , Cohen MH , Kirkwood C. , Russel NC Discussing complementary therapies in an oncology setting. J Soc Integr Oncol. 2007;5:18-24.

12.

Tasaki K. , Maskerinec G. , Shumay DM , Tatsumura Y. , Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11:212-220.

13.

Roberts CS , Baker F. , Hann D. , et al. Patient-physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol. 2005;23:35-60.

14.

Schofield PE , Juraskova I. , Butow PN How oncologists discuss complementary therapy with their patients: an audio-tape audit. Support Care Cancer . 2003;11:348-355.

15.

Adler SR , Fosket JR Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract . 1999;48: 453-458.

16.

Lerman C. , Daly M. , Walsh WP , et al. Communication between patients with breast cancer and health care providers: determinants and implications. Cancer. 1993;72:2612-2620.

17.

Hann DM , Baker F. , Denniston MM Oncology professionals’ communication with cancer patients about complementary therapy: a survey. Complement Ther Med. 2003 ;11:184-190.

18.

Pappas S. , Perlman A. Complementary and alternative medicine: the importance of doctor-patient communication . Med Clin North Am. 2002;86:1-10.

19.

Fallowfield LJ , Hall A. , Maguire GP , Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990;301: 575-580.

20.

Maguire P. , Tait A. , Brooke M. , Thomas C. , Sellwood R. Effect of counselling on the psychiatric morbidity associated with mastectomy . BMJ. 1980;281:1454-1456.

21.

Butow P. , Devine R. , Boyer M. , Pendlebury S. , Jackson M. , Tattersall MH Cancer consultation preparation package: changing patients but not physicians is not enough. J Clin Oncol. 2004 ;22:4401-4409.

22.

Butow P. , Juraskova I. , Brown R. , et al. A randomised controlled trial of consultation skills training (IBCSG 33-03) to improve communication about cancer treatment options and clinical trials: interim analyses using Australian & New Zealand data . Psychooncology. 2006;15:S91.

23.

Spielberger CD Manual for the State-Trait Anxiety. Palo Alto, CA: Consulting Psychologists Press; 1983.

24.

Paltiel O. , Avitzour M. , Peretz T. , et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol. 2001;19:2439-2448.

25.

Ernst E. , Cassileth BR The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer. 1998;83:777-782.

26.

Burstein HJ , Gelber S. , Guadagnoli E. , Weeks JC Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733-1740.

27.

Ben-Ayre E. , Frenkel M. , Bar-Sela G. , Margalit RS , Hermoni D. , Kuten A. Teaching complementary medicine at an oncology department. J Cancer Educ. 2008;23:46-50.

28.

Schofield PE , Diggins J. , Charleson C. , Marigliani R. , Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. In press.